Frontiers in Aging Neuroscience

Papers
(The H4-Index of Frontiers in Aging Neuroscience is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases307
Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease287
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2019201
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature190
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study171
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases158
Cellular Senescence in Brain Aging151
Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab139
The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis135
The Impact of Disease Comorbidities in Alzheimer's Disease132
Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects127
Alzheimer’s Disease: An Update and Insights Into Pathophysiology103
Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?96
Functional Aging in Male C57BL/6J Mice Across the Life-Span: A Systematic Behavioral Analysis of Motor, Emotional, and Memory Function to Define an Aging Phenotype95
The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey82
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease82
Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration81
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain81
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review79
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury72
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine71
Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort70
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough70
Grip Strength and the Risk of Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis of Longitudinal Cohort Studies68
Normal Aging Induces Changes in the Brain and Neurodegeneration Progress: Review of the Structural, Biochemical, Metabolic, Cellular, and Molecular Changes68
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases67
COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study66
Hearing Loss and Cognition: What We Know and Where We Need to Go64
Prevalence of Alzheimer's Disease and Parkinson's Disease in China: An Updated Systematical Analysis62
Update on the Mechanism and Treatment of Sevoflurane-Induced Postoperative Cognitive Dysfunction61
Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson’s Disease59
Effects of Virtual Reality Intervention on Cognition and Motor Function in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review and Meta-Analysis58
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the 56
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease56
Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review55
Role of the Extracellular Matrix in Alzheimer’s Disease55
Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target54
Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?53
Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease52
Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech51
Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention51
Characterization of Age-Related Differences in the Human Choroid Plexus Volume, Microstructural Integrity, and Blood Perfusion Using Multiparameter Magnetic Resonance Imaging50
Multiple Roles in Neuroprotection for the Exercise Derived Myokine Irisin49
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications48
Enteric Nervous System: The Bridge Between the Gut Microbiota and Neurological Disorders48
The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago48
Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action47
Decreased Retinal Vascular Density in Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI): An Optical Coherence Tomography Angiography (OCTA) Study47
0.052073001861572